Taiyi Capital

Taiyi Capital is a prominent Chinese venture capital and asset management firm that maintains a significant strategic focus on the life sciences and healthcare sectors. The firm operates specialized healthcare funds that invest across the entire industry value chain, including innovative drug development, medical devices, and digital health technologies. Taiyi Capital is known for its deep industry expertise and its ability to provide both financial backing and operational support to high-growth biotech companies in the Asia-Pacific region. By leveraging a robust network of clinical and regulatory partners, the firm facilitates the commercialization of breakthrough medical innovations. Its portfolio includes several leading biotechnology companies that have successfully transitioned from early-stage research to clinical-stage development and public listing.